HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Phase II trial of anaxirone in advanced non-small cell lung cancer.

AuthorsH H Fiebig, H Henss, H Arnold, F von Bültzingslöwen, M Klee, W Queisser, M Peukert
JournalCancer treatment reports (Cancer Treat Rep) Vol. 71 Issue 5 Pg. 539-40 (May 1987) ISSN: 0361-5960 [Print] UNITED STATES
PMID3567979 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Triazoles
  • anaxirone
Topics
  • Adenocarcinoma (drug therapy)
  • Adult
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy)
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms (drug therapy)
  • Male
  • Middle Aged
  • Triazoles (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: